FutureChem   Report issue

For profit Phase 1 Phase 3
Founded: Seoul Korea, Republic of (1999)

Organization Overview

First Clinical Trial
2020
NCT04509557
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

FutureChem